Germany· DE-A57-3d27317a3d545e67
Natriumglycerophosphat-Ampulle Fresenius
A medicinal product containing sodium glycerophosphate pentahydrate, registered in Germany by Fresenius Kabi Deutschland Gmbh.
Checked against EMA Article 57 (European Union) on
Informational only — not a medical device.
The record
At a glance
EMA Article 57 (European Union)- Active substance
- Sodium Glycerophosphate Pentahydrate
- Manufacturer
- Fresenius Kabi Deutschland Gmbh
- Country
- Germany (DE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- EMA Article 57 (European Union)
- Last checked
- September 30, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Sodium glycerophosphate pentahydrate in 7 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumGlycophos 20 mlFresenius Kabi
- PolandGlycophosFresenius Kabi AB
- United KingdomGlycophos 4.32g/20ml concentrate for solution for infusion vialsFresenius Kabi Ltd
- CzechiaSODIUM GLYCEROPHOSPHATE FRESENIUSFresenius Kabi s.r.o., Praha
- FinlandGlycophosFresenius Kabi AB
- FranceGLYCEROPHOSPHATE DE SODIUM KABI 216 mg/mL (1 mmol/mL), solution à diluer pour perfusionFRESENIUS KABI FRANCE
- NorwayGlycophosFresenius Kabi
Authorised across Europe · EMA
The same active substance is authorised in 19 EEA countries. Names it is sold under:
- Austria · Glycophos
- Belgium · Glycophos
- Cyprus · Glycophos
- Czechia · Sodium Glycerophosphate Fresenius
- Denmark · Glycophos
- Spain · Glycophos
- Finland · Glycophos
- France · Glycerophosphate De Sodium
- Greece · Glycophos
- Hungary · Nátrium-Glicerin-Foszfát Fresenius
- Italy · Glycophos
- Lithuania · Glycophos
- Latvia · Glycophos
- Netherlands · Glycophos
- Poland · Glycophos
- Portugal · Glycophos
- Romania · Glycophos
- Sweden · Glycophos
- Slovakia · Sodium Glycerophosphate Fresenius
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/1279140f-e601-49a6-9c55-e6ac884fceba GET /v1/drugs/1279140f-e601-49a6-9c55-e6ac884fceba?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pzn": null,
"route": "Intravenous Use",
"source": "ema_art57_de",
"ma_number": null,
"substance": "Sodium Glycerophosphate Pentahydrate",
"atc_from_source": null,
"authorisation_country": "Germany"
}See everything about sodium glycerophosphate pentahydrate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.